Similar Posts
Stigma: The Invisible Barrier by Herman Joseph and Joycelyn Woods
ByAdminAdmin 12/13/2021Herman Joseph, Ph.D. is a member of NAMA’s Advisory Board and has been involved in methadone treatment and research since it’s beginning. This article is excerpted from Herman Joseph’s dissertation on stigma. Methadone maintenance treatment has been subjected to professional trivialization and misunderstandings, has consistently received sensationalized negative media coverage and been the target of…
MOVING FORWARD
ByAdminAdmin 10/25/2021Invitational Conference on Drug User Activism International Drug User Day 2003, October 31st/November 1st Copenhagen, Denmark The Danish Drug Users Union – BrugerForeningen and the Dutch National Interest Group of Drug Users – Landelijk Steunpunt Druggebruikers sponsor “Moving Forward” a meeting on drug user activism. The gathering was to mark both the International Drug User…
CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)
ByAdminAdmin 09/12/2022Medication Assisted Treatment (MAT) Advocacy The National Alliance for Medication Assisted Recovery (NAMA-R) holds the view that every individual who believes in Medication Assisted Treatment (MAT) is at least a potential Certified MAT Advocate (CMA). We encourage all supporters of MAT, patient and non-patient, to become Certified MAT Advocates so that all energies directed toward the advancement of…
Federal Regulations & Accreditation Resources
ByAdminAdmin 08/24/2021Federal Regulations & Documents Code of Federal Regulations. Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Final Rule 21 CRF 291, 42 CRF 8. (Text) Federal Regulations (PDF Format) . Code of Federal Regulations. Confidentiality of Alcohol and Drug Abuse Patient Records (PDF Format). CSAT Accreditation Page. CSAT Guidelines for the accreditation of…